文献简介

出版社:

作  者:Karolyn A.Wanat, MD Erika Reid, MD William Kamiyango,MD Nader Kim El-Mallawany, MD Carrie L. Kovarik,MD

编  号:

关键字:Gorlin Syndrome; Vismodegib; TrichodysplasiaSpinulosa

年  份:   点击量:680

提  供:JAMA Dermatology September 2014 Volume 150, Number 9

文献摘要 全文翻译

Vismodegib is approved by the US Food and Drug Administrationfor the treatment of unresectable basal cell carcinoma(BCC) as well as for Gorlin syndrome (basal cell nevus syndrome).

Vismodegib已被美国食品和药物管理局批准用于治疗手术不能切除的基底细胞癌(BCC)以及Gorlin综合症(基底细胞痣综合征)。